000280051 001__ 280051
000280051 005__ 20250824001730.0
000280051 0247_ $$2doi$$a10.1080/21678421.2025.2488296
000280051 0247_ $$2pmid$$apmid:40219902
000280051 0247_ $$2ISSN$$a2167-8421
000280051 0247_ $$2ISSN$$a2167-9223
000280051 0247_ $$2altmetric$$aaltmetric:176099356
000280051 037__ $$aDZNE-2025-00888
000280051 041__ $$aEnglish
000280051 082__ $$a610
000280051 1001_ $$aLapp, Hanna Sophie$$b0
000280051 245__ $$aSOD1-ALS mimicking an inflammatory neuropathy: a case report.
000280051 260__ $$aAbingdon$$bTaylor Francis Group$$c2025
000280051 3367_ $$2DRIVER$$aarticle
000280051 3367_ $$2DataCite$$aOutput Types/Journal article
000280051 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753362911_6604
000280051 3367_ $$2BibTeX$$aARTICLE
000280051 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000280051 3367_ $$00$$2EndNote$$aJournal Article
000280051 520__ $$aWe present the case of a 36-year-old patient with a rapidly progressing SOD1-ALS, who was initially diagnosed as inflammatory acute motor axonal neuropathy due to contrast-enhancement of the lumbar spinal cord and a pure secondary motor neuron phenotype. Since the initiation of tofersen, disease progression and neurofilament levels impressively declined.
000280051 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000280051 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000280051 650_7 $$2Other$$aALS
000280051 650_7 $$2Other$$aAmyotrophic lateral sclerosis
000280051 650_7 $$2Other$$aMRI
000280051 650_7 $$2Other$$aSOD1 mutation
000280051 650_7 $$2Other$$acontrast enhancement
000280051 650_7 $$0EC 1.15.1.1$$2NLM Chemicals$$aSuperoxide Dismutase-1
000280051 650_7 $$2NLM Chemicals$$aSOD1 protein, human
000280051 650_2 $$2MeSH$$aHumans
000280051 650_2 $$2MeSH$$aAdult
000280051 650_2 $$2MeSH$$aAmyotrophic Lateral Sclerosis: genetics
000280051 650_2 $$2MeSH$$aAmyotrophic Lateral Sclerosis: diagnosis
000280051 650_2 $$2MeSH$$aDiagnosis, Differential
000280051 650_2 $$2MeSH$$aMale
000280051 650_2 $$2MeSH$$aSuperoxide Dismutase-1: genetics
000280051 650_2 $$2MeSH$$aDisease Progression
000280051 7001_ $$0P:(DE-2719)2811849$$aGünther, René$$b1$$eLast author$$udzne
000280051 773__ $$0PERI:(DE-600)2705061-0$$a10.1080/21678421.2025.2488296$$gVol. 26, no. 5-6, p. 591 - 594$$n5-6$$p591 - 594$$tAmyotrophic lateral sclerosis & frontotemporal degeneration$$v26$$x2167-8421$$y2025
000280051 8564_ $$uhttps://pub.dzne.de/record/280051/files/DZNE-2025-00888.pdf$$yOpenAccess
000280051 8564_ $$uhttps://pub.dzne.de/record/280051/files/DZNE-2025-00888.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000280051 909CO $$ooai:pub.dzne.de:280051$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000280051 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811849$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000280051 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000280051 9141_ $$y2025
000280051 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-01
000280051 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-01
000280051 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-01
000280051 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000280051 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bAMYOTROPH LAT SCL FR : 2022$$d2025-01-01
000280051 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-01
000280051 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-01
000280051 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-01
000280051 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000280051 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-01
000280051 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-01
000280051 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-01
000280051 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-01
000280051 9201_ $$0I:(DE-2719)1710012$$kAG Falkenburger$$lTranslational Parkinson Research$$x0
000280051 980__ $$ajournal
000280051 980__ $$aVDB
000280051 980__ $$aUNRESTRICTED
000280051 980__ $$aI:(DE-2719)1710012
000280051 9801_ $$aFullTexts